Friday, 20 March 2020
COVID 19 - a Different Perspective
Sunday, 23 February 2020
Saturday, 22 February 2020
Wednesday, 19 February 2020
SPACEX SAYS IT WILL LAUNCH SPACE TOURISTS AS SOON AS NEXT YEAR
SpaceX announced a partnership this week with space tourism Space Adventures to start launching passengers to orbit aboard a Crew Dragon spacecraft starting as early as 2021, TechCrunch reports.
SpaceX says it will send four privately-paying space tourists to orbit the Earth for five days in its Crew Dragon capsule between “late-2021 and mid-2022,” according to CNBC.
“This historic mission will forge a path to making spaceflight possible for all people who dream of it, and we are pleased to work with the Space Adventures’ team on the mission,” SpaceX president and COO Gwynne Shotwell said in a statement.
Space Adventures already sells seats on Russian Soyuz rockets.
SpaceX’s passenger-carrying Crew Dragon capsule, developed as part of NASA’s Commercial Crew Program, has so far completed a successful test trip and docking maneur to the International Space Station last year, but has yet to make the journey with any passengers on board.
Earlier this year, SpaceX tested its space taxi’s emergency abort system in dramatic fashion, intentionally blowing up a Falcon 9 rocket in the process.
READ MORE: SpaceX and new partner announce space tourism launches on Dragon starting as early as 2021 [TechCrunch]
SCIENTISTS CREATE ARTIFICIAL GENOME THAT CAN REPRODUCE
German scientists say that for the first time ever, they’ve created a lab-grown artificial genome that can reproduce itself like a natural one.
It’s not quite one of those replicants from “Blade Runner,” but it’s a step toward the holy grail of synthetic biology: fully artificial organisms that can survive and reproduce like the real thing.
In a paper published in the journal Nature Communications this week, researchers from the Max Planck Institute of Biochemistry describe how they assembled genomes made up of blueprints for proteins — and demonstrated that it was capable of replicating 116 kilobytes worth of its own RNA and DNA.
Next up, according to a press release, the team plans to build an “enveloped system” that can reproduce like this last one — but also consume nutrition and dispose of waste, like a living cell.
READ MORE: Reproductive genome from the laboratory [Max Planck Society]
Thursday, 30 January 2020
THESE ARE THE SYMPTOMS OF CORONAVIRUS
As the deadly coronavirus 2019-nCoV spreads throughout the world, doctors are getting a better understanding of what symptoms and warning signs to keep an eye out for.
Some extreme cases involve patients coughing up blood or going into septic shock. More typically, however, symptoms remain milder — potentially letting some cases slip under the radar and worsening the outbreak.
Like other coronaviruses, 2019-nCoV can cause pneumonia and other respiratory and cardiovascular conditions: coughing, fever, fatigue, and soreness. Because the outbreak is in the middle of flu season, that can make distinguishing between the two difficult.
As the disease progresses, it can cause more severe symptoms including difficulty breathing, kidney injury, and heart damage.
The virus is most dangerous for the elderly or people who are already sick — the mortality rate is substantially higher within those particular groups than the general population.
Screening for new cases is also difficult because 2019-nCoV patients can spread the disease while they remain asymptomatic for as long as two weeks — compared to most viral infections which cause symptoms within the first few days.
As 2019-nCoV, the coronavirus that emerged in China last month, continues to spread to over a dozen countries, it’s becoming increasingly clear that the elderly and chronically ill are at a greater risk than the general population.
The coronavirus can cause symptoms ranging in severity from fever and fatigue to pneumonia and septic shock. But older people, and people who were already sick before contracting 2019-nCoV, seem to be getting hit harder,
Sunday, 26 January 2020
The Play Theory of Hunter-Gatherer Egalitarianism.
Wednesday, 22 January 2020
SCIENTISTS DISCOVER IMMUNE CELL THAT KILLS MOST CANCERS
The treatment leverages T-cells, a type of white blood cell that helps our bodies’ immune systems by scanning for and killing abnormal cells. For background, scientists have recently started harnessing that ability in the fight against cancer through CAR-T, which involves removing T-cells from a patient’s blood and genetically engineering them to seek out and destroy cancer cells.
While promising, CAR-T has limitations. It’s patient-specific, works against only a small number of cancers, and isn’t effective against solid tumors, which comprise the majority of cancers.
On Monday, researchers from Cardiff University published a new study in the journal Nature Immunology detailing their discovery of a T-Cell equipped with a new type of T-cell receptor (TCR) that recognizes a molecule called MR1.
This molecule appears on the surface of many types of cancer cells as well as healthy cells, but T-cells equipped with this TCR know to kill only cancer cells.
And not just the kind linked to a single type of cancer, either. When the Cardiff researchers equipped T-cells in lab tests with this new TCR, the cells killed lung, skin, blood, colon, breast, bone, prostate, ovarian, kidney and cervical cancer cells — all while ignoring healthy cells.
In another lab test, the team modified the T-cells of melanoma patients to express the newly discovered TCR and found that the cells could then target and destroy both that patient’s own cancer cells and the cancer cells of other patients.
The team has yet to test the modified T-cells in actual cancer patients, but when tested in mice injected with human cancers, the cells recognized the MR1 molecule and exhibited “encouraging” cancer-killing abilities, according to a Cardiff press release.
The Cardiff scientists now plan to conduct additional tests. If those goes as hoped, the treatment could be ready for patients within a few years, researcher Andrew Sewell said in the press release.
“Cancer-targeting via MR1-restricted T-cells is an exciting new frontier,” he added. “It raises the prospect of a ‘one-size-fits-all’ cancer treatment; a single type of T-cell that could be capable of destroying many different types of cancers across the population. Previously nobody believed this could be possible.”
Friday, 10 January 2020
Police have caught yet another driver abusing Tesla’s Autopilot system — but this time, he was cleaning his tooth
In its current form, Tesla’s Autopilot system can only assist drivers, not free them from the task of driving altogether — a distinction the company makes clear on its website.
“Autopilot enables your car to steer, accelerate, and brake automatically within its lane,” Tesla writes. “Current Autopilot features require active driver supervision and do not make the vehicle autonomous.”
However, that hasn’t stopped countless Tesla owners from letting Autopilot take over while they sleep, drive drunk, and even having sex.
After a video of yet another sleeping Tesla owner made the rounds online in September, Tesla released a statement clarifying that its driver-monitoring system issues warnings designed to prevent drivers from relying on Autopilot.
Clearly, those warnings didn’t stop the flossing Tesla owner, demonstrating once again that the company should probably be doing more to keep its drivers’ attention on the road.
READ MORE: Tesla driver charged with careless driving for flossing his teeth on Autopilot at 84 mph [Electrek]